Search research articles
Contact Us
Filters
Showing results (491-500 of 541) with videos related to
Page
of 55
Sort By:
Neurology
|
July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
Jennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
Brain : a Journal of Neurology
|
August 12, 2025
Design considerations for C9orf72 disease prevention trials
Michael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
PLOS Global Public Health
|
June 26, 2025
Attractive targeted sugar baits for malaria control in western Kenya (ATSB-Kenya) - Effect of ATSBs on epidemiologic and entomologic indicators: A Phase III, open-label, cluster-randomised, controlled trial
Caroline Ogwang, Aaron M Samuels, Daniel P McDermott, et al.
Neurology. Genetics
|
August 15, 2022
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results
Stella Jensen-Roberts, Taylor L Myers, Peggy Auinger, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Christen Dillard, Meagan Kiyohara, Vei Mah, et al.
Muscle & Nerve
|
April 29, 2016
Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy
Amy Pasternak, Georgios Sideridis, Maria Fragala-Pinkham, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors
James J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Plos One
|
April 9, 2013
SMA-MAP: a plasma protein panel for spinal muscular atrophy
Dione T Kobayashi, Jing Shi, Laurie Stephen, et al.
Nature Reviews. Neurology
|
May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D Huey, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Page
of 55
Search research articles
Search
Showing results (491-500 of 541) with videos related to
Sort By:
Page
of 55
Neurology
|
July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
Jennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
Brain : a Journal of Neurology
|
August 12, 2025
Design considerations for C9orf72 disease prevention trials
Michael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
PLOS Global Public Health
|
June 26, 2025
Attractive targeted sugar baits for malaria control in western Kenya (ATSB-Kenya) - Effect of ATSBs on epidemiologic and entomologic indicators: A Phase III, open-label, cluster-randomised, controlled trial
Caroline Ogwang, Aaron M Samuels, Daniel P McDermott, et al.
Neurology. Genetics
|
August 15, 2022
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results
Stella Jensen-Roberts, Taylor L Myers, Peggy Auinger, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Christen Dillard, Meagan Kiyohara, Vei Mah, et al.
Muscle & Nerve
|
April 29, 2016
Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy
Amy Pasternak, Georgios Sideridis, Maria Fragala-Pinkham, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors
James J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Plos One
|
April 9, 2013
SMA-MAP: a plasma protein panel for spinal muscular atrophy
Dione T Kobayashi, Jing Shi, Laurie Stephen, et al.
Nature Reviews. Neurology
|
May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D Huey, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Page
of 55